FDA Adverse Event Malfunction Summary report: N

ARCHITECT CA 19-9XR

MDR report key: 2803237 · Received October 24, 2012

Report

Report Number
1415939-2012-02050
Event Type
Malfunction
Date Received
October 24, 2012
Date of Event
September 24, 2012
Report Date
October 2, 2012
Manufacturer
ABBOTT LABORATORIES
Product Code
NIG
PMA / PMN Number
K052000
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SP
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE TREND REVIEW IDENTIFIED NORMAL COMPLAINT ACTIVITY FOR THE ISSUE UNDER INVESTIGATION. THE TICKET REVIEW FOR THE LIKELY CAUSE LOTS IDENTIFIED ATYPICAL COMPLAINT ACTIVITY FOR THE ISSUE UNDER REVIEW. ACCURACY TESTING WAS COMPLETED ON LIKELY CAUSE LOT 13516M500; TESTING MEETS ACCEPTANCE CRITERIA. A LABELING REVIEW WAS ALSO PEFORMED. THE INVESTIGATION RESULTS SHOW THAT THERE IS NO PRODUCT DEFICIENCY, HOWEVER A MALFUNCTION WAS IDENTIFIED. THIS INVESTIGATION INDICATES THAT THE ARCHITECT CA19-9XR REAGENT KITS ARE PERFORMING AS INTENDED AND NO NEW ISSUES WERE IDENTIFIED.

Additional Manufacturer Narrative · 1

(B)(4). AN EVALUATION IS IN PROGRESS. A FOLLOWUP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE.

Description of Event or Problem · 1

THE ACCOUNT GENERATED INCONSISTANT ARCHITECT CA19-9XR RESULTS ON ONE PATIENT (PATIENT 3, SID (B)(6)). NO INFORMATION WAS PROVIDED REGARDING THE EXPECTED/CORRECT CA19-9 RESULT FOR PATIENT 3. NO SPECIFIC PATIENT INFORMATION WAS PROVIDED. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.DATA PROVIDED:PATIENT 3 ((B)(6))ARCHITECT CA19-9XR RESULTS:24SEP2012 = 21.73 U/ML;24SEP2012 = 38.92 U/ML;25SEP2012 = 15.70 U/ML;25SEP2012 = 18.45 U/ML.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ARCHITECT CA 19-9XR NIG ABBOTT LABORATORIES 13516M500

Patients

Seq Age Sex Outcome Treatment
1 ARCHITECT I2000SR: LIST 03M74-97| SERIAL (B)(4).